144Filing Date: Aug 5, 2026
Resmed (RMD)
Insider Proposed Sale Notice
View SEC Filing
ACC: 0001628280-26-053728
Sale Plan
Peter C Farrell
Director·Resmed
Proposed
CommonNYSE
Shares8.00K
Est. DateAug 5
Market Value$1.80M
BrokerMerrill Lynch
AcquisitionStock Option · Peter C Farrell
Acquired DateNov 11, 2024
Amount Acquired1.24K
10b5-1 Plan Adoption08/12/2025
% Outstanding0.0055%
10b5-1
Exercise / Payment Details
Paid: Nov 11, 2024Method: Cash
Signature & Compliance expand_more
Notice DateAug 5, 2026
10b5-1 Plan Adoption08/12/2025
Signature PETER C FARRELL
Issuer Info expand_more
CompanyResMed INC
CIK0000943819
Phone858-746-2400
Address9001 Spectrum Center Blvd, SAN DIEGO, CA 92123